CONMED (CNMD) PT Raised to $45 at Piper Sandler
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.93 +0.73%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien raised the price target on CONMED (NYSE: CNMD) to $45.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Macquarie Downgrades Mercari, Inc (4385:JP) (MRCIF) to Neutral
- Opus Genetics (IRD) PT Raised to $13 at Wedbush
- Tokyo Ohka Kogyo Co., Ltd (4186:JP) (TOKCF) PT Lowered to JPY9,500 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
